SCIPROM SARL

Their core work

SCIPROM is a Swiss SME specializing in scientific project management, dissemination, and exploitation support for EU-funded research consortia. Their presence across radically different domains — from neurodegenerative disease to beekeeping to nanotechnology to medical isotopes — indicates they provide cross-cutting services (project coordination support, data management, communication, impact planning) rather than domain-specific research. Based in Saint-Sulpice near EPFL, they serve as a professional services partner that helps research consortia run smoothly and maximize impact. Their consistent modest funding shares across all 11 projects confirm a service-provider role embedded within large collaborative teams.

What they specialise in

How they've shifted over time

SCIPROM's early H2020 work (2016–2019) clustered around biomedical and advanced sensor topics — neurodegeneration, gas sensor systems-on-chip, meniscus regeneration, and diabetes research. From 2019 onward, their portfolio broadened significantly into governance and policy (TiGRE), agriculture (B-GOOD), energy harvesting (GreEnergy), and digital health (DIGIPREDICT). This widening scope reinforces that SCIPROM's core competence is project services rather than any single scientific domain, and they have been expanding into increasingly diverse research areas over time.

SCIPROM is diversifying into more applied and societal topics (governance, agriculture, digital health), suggesting they are positioning as a versatile project services partner for any research domain.

How they like to work

SCIPROM exclusively joins consortia as a participant — they have never coordinated an H2020 project. With 134 unique partners across 23 countries, they operate as a connector node rather than a repeat-partnership organization, entering new consortia with new partners each time. This makes them easy to bring into a consortium: they are experienced team players with no competitive overlap with domain-specific partners, and they adapt quickly to new topics and team configurations.

SCIPROM has built a broad European network of 134 unique partners across 23 countries through 11 projects. Their Swiss base near EPFL and Lausanne gives them proximity to a major research ecosystem, but their collaborations span the full EU geography with no strong single-country bias.

What sets them apart

SCIPROM's defining trait is extreme domain versatility — few SMEs can claim meaningful participation in projects spanning neurodegenerative disease, beekeeping, nanotechnology, European governance, and medical isotopes. This breadth makes them a reliable project management and dissemination partner for any consortium regardless of scientific topic. Their Swiss base, SME status, and professional services focus mean they add operational capacity without competing with research partners for scientific credit.

Highlights from their portfolio

• PRISMAP
  Largest single funding (€566K) — the European medical isotope programme, showing SCIPROM can support high-budget infrastructure-type projects.
• DIGIPREDICT
  Combines Edge AI, digital twins, and wearables for disease prediction — represents SCIPROM's move into applied digital health.
• B-GOOD
  Unusual topic (computational beekeeping guidance) with strong data platform and multi-actor approach keywords, highlighting SCIPROM's data management capabilities.